BEACHWOOD, Ohio – Trailhead Biosystems Inc. (www.trailbio.com), a biotechnology company advancing human cell innovation, has secured $20 million in financing. Trailhead specializes in precisely differentiating induced pluripotent stem cells (iPSCs) into functional human cell types—unlocking new possibilities for research and cell therapy. Through its proprietary High-Dimensional Design of Experiments (HD-DoE®) platform, Trailhead optimizes differentiation with exceptional accuracy, enabling […]

Financing led by Superhero Capital backed by NGL Ventures, Coinvest Capital and angel investors Building on strong international R&D customer base across biotech, pharma and academia Transforming multi-omics data into functional discoveries Addressing a potential USD 16 billion market VUGENE, a Lithuania-based multi-omics data analysis company, today announced the closing an investment round of €1 million, […]

Spin out expected to unlock value by accelerating data storage technology development and allowing each company to focus strategically on its unique products, customers and investors Atlas Data Storage, a newly formed company, will focus solely on DNA data storage technology and commercialization, with $155 million in seed financing round including ARCH Venture Partners, Deerfield […]

PORTLAND, Ore. — Araceli Biosciences, a pioneering biotechnology company revolutionizing high-content imaging and AI-powered analysis, today announced the successful completion of its Seed funding round, raising $7.2 million in new equity investment and converting $4.0 million in SAFEs, bringing total financing since Araceli’s spinout from Phoseon Technology to $11.2M. This funding will accelerate Araceli’s commercial expansion, scale manufacturing, and advance its […]

As momentum builds, Deepcell advances commercial scale-up and market expansion for its AI-powered single cell analysis platform.  MENLO PARK, CA – Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, today announced the appointment of Janette Phi as Chief Business and Commercial Officer. The company also completed an initial closing of a […]

BOHEMIA, N.Y. — Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced today that it has successfully secured approximately $1.6 million in a private placement to advance the Company’s SBI’s DOTS Platform, a real-time bioprocessing system and for general corporate use. The offering consisted of 1,550,000 shares […]

ChromaGenix will combine industry expertise, academic innovation, and $35 million in planned investment to develop and scale next-generation purification technologies for gene therapies, vaccines, and immunotherapies. LigaTrap Technologies (now ChromaGenix) is an innovative North Carolina biotechnology company offering proprietary purification technologies for production of antibody-based medications, viral vaccines, and gene therapies. We’re pleased to announce […]

CARLSBAD, CA – Pictor, a global leader in multiplex proteomics solutions, is excited to announce the establishment of its U.S. headquarters in Carlsbad, California, marking a significant milestone in its strategic growth and commitment to advancing cutting-edge solutions for laboratories worldwide. This transformation solidifies Pictor Holdings Inc. as the parent company, which will continue to proudly operate […]

Munich-based lab automation startup raised €2.77M in a pre-seed funding round led by NAP (formerly Cavalry Ventures) with PUSH, Acurio Ventures, OMA Business Angels, and LANA Ventures also participating. Fundraising Announcement Munich – UniteLabs, a startup specializing in lab automation for biotechnology, has raised €2.77 million in a pre-seed funding round led by NAP (formerly Cavalry Ventures). […]

VANCOUVER, British Columbia — Semaphore Solutions, a leader in laboratory informatics solutions, announces a new investment from Cypress Ridge Capital (“CRC”) to further accelerate the growth of its flagship platform, Labbit. The growth equity investment builds on Cypress Ridge’s initial investment in February 2023 and supports the continued organic and inorganic expansion of Labbit as […]